Cargando…
Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation
BACKGROUND: Previous studies demonstrated impaired lipid metabolism and augmented aerobic glycolysis in AF. The authors aimed to investigate whether the use of metformin, an AMPK activator, could reverse this metabolic remodeling in chronic AF and to explore the underlying mechanisms. METHODS: We co...
Autores principales: | Liu, Yaozhong, Bai, Fan, Liu, Na, Zhang, Baojian, Qin, Fen, Tu, Tao, Li, Biao, Li, Jiayi, Ma, Yingxu, Ouyang, Feifan, Liu, Qiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998172/ https://www.ncbi.nlm.nih.gov/pubmed/32013885 http://dx.doi.org/10.1186/s12872-020-01359-7 |
Ejemplares similares
-
Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway
por: Bai, Fan, et al.
Publicado: (2019) -
Mendelian Randomization Integrating GWAS, eQTL, and mQTL Data Identified Genes Pleiotropically Associated With Atrial Fibrillation
por: Liu, Yaozhong, et al.
Publicado: (2021) -
Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability
por: Li, Biao, et al.
Publicado: (2020) -
Quantitative acetylated proteomics on left atrial appendage tissues revealed atrial energy metabolism and contraction status in patients with valvular heart disease with atrial fibrillation
por: Tu, Tao, et al.
Publicado: (2022) -
Comparison between High-Power Short-Duration and Conventional Ablation Strategy in Atrial Fibrillation: An Updated Meta-Analysis
por: Li, Mohan, et al.
Publicado: (2022)